Search

Author/Creator Chiwata, Masahiko

1. No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki. Issue 12 (23rd October 2020)

Authors:
Toriyama, Eo; Hata, Tomoko; Yokota, Ken‐ichi; Chiwata, Masahiko; Kamijo, Rena; Hashimoto, Miki; Taguchi, Masataka; Horai, Makiko; Matsuo, Masatoshi; Matsuo, Emi; Takasaki, Yumi; Kawaguchi, Yasuhisa; Itonaga, Hidehiro; Sato, Shinya; Ando, Koji; Sawayama, Yasushi; Taguchi, Jun; Imaizumi, Yoshitaka;...
Journal:
Cancer science
Issue:
Volume 111:Issue 12(2020)
Page Start:
4490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Treatment with mogamulizumab or lenalidomide for relapsed adult T‐cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience. Issue 2 (26th January 2020)

Authors:
Sakamoto, Hikaru; Itonaga, Hidehiro; Sawayama, Yasushi; Furumoto, Takafumi; Fujioka, Machiko; Chiwata, Masahiko; Toriyama, Eo; Kasai, Sachie; Nakashima, Jun; Horai, Makiko; Kato, Takeharu; Sato, Shinya; Ando, Koji; Taguchi, Jun; Imaizumi, Yoshitaka; Yoshida, Shinichiro; Hata, Tomoko; Moriuchi, Yu...
Journal:
Hematological oncology
Issue:
Volume 38:Issue 2(2020)
Page Start:
162
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search